KEGG pathway analysis suggested that morusin may exert its anti-NPC effects through modulation of the MAPK, IL-17, and NF-κB signaling pathways, with particular involvement of the previously screened key proteins. The gene discussed is NFKB1; the disease is nasopharyngeal carcinoma.